.jpg?format=webp&width=780)
Over the past decade, transcatheter mitral valve replacement (TMVR) technologies have evolved to improve outcomes for patients with severe mitral regurgitation (MR) deemed unsuitable for conventional mitral valve (MV) surgery. Unfortunately, rapid reduction in LV cavity size following MR elimination may result in relative LV outflow tract obstruction (LVOTO), irrespective of the intrinsic risk of LVOTO associated with TMVR. Nevertheless, TMVR on a beating heart affords the opportunity to study real‐time invasive cardiac indices in high‐risk patients with acute reversal of severe MR.
Like
Save
Share